Jane Street Group LLC lowered its stake in shares of Quanterix Co. (NASDAQ:QTRX – Free Report) by 14.2% during the 3rd quarter, Holdings Channel.com reports. The fund owned 47,369 shares of the company’s stock after selling 7,836 shares during the quarter. Jane Street Group LLC’s holdings in Quanterix were worth $614,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Portolan Capital Management LLC lifted its stake in shares of Quanterix by 31.4% in the 3rd quarter. Portolan Capital Management LLC now owns 2,520,686 shares of the company’s stock worth $32,668,000 after purchasing an additional 602,656 shares during the period. Easterly Investment Partners LLC lifted its stake in shares of Quanterix by 26.5% in the 3rd quarter. Easterly Investment Partners LLC now owns 876,133 shares of the company’s stock worth $11,355,000 after purchasing an additional 183,387 shares during the period. State Street Corp lifted its stake in shares of Quanterix by 2.2% in the 3rd quarter. State Street Corp now owns 836,443 shares of the company’s stock worth $10,840,000 after purchasing an additional 18,050 shares during the period. Emerald Advisers LLC lifted its stake in shares of Quanterix by 5.6% in the 3rd quarter. Emerald Advisers LLC now owns 719,217 shares of the company’s stock worth $9,321,000 after purchasing an additional 38,230 shares during the period. Finally, Emerald Mutual Fund Advisers Trust lifted its stake in shares of Quanterix by 0.8% in the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 563,247 shares of the company’s stock worth $7,300,000 after purchasing an additional 4,406 shares during the period. Institutional investors own 86.48% of the company’s stock.
Wall Street Analysts Forecast Growth
Separately, TD Cowen increased their price objective on shares of Quanterix from $13.50 to $16.00 and gave the stock a “hold” rating in a research note on Wednesday, November 13th.
Quanterix Trading Up 12.3 %
Quanterix stock opened at $12.08 on Friday. The firm has a 50 day moving average of $12.09 and a 200 day moving average of $12.73. The firm has a market capitalization of $465.37 million, a price-to-earnings ratio of -11.50 and a beta of 1.33. Quanterix Co. has a 12-month low of $9.87 and a 12-month high of $29.70.
Quanterix Company Profile
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Further Reading
- Five stocks we like better than Quanterix
- Market Cap Calculator: How to Calculate Market Cap
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Insider Trading – What You Need to Know
- Nebius Group: The Rising Star in AI Infrastructure
- Where to Find Earnings Call Transcripts
- MarketBeat Week in Review – 12/30 – 1/03
Want to see what other hedge funds are holding QTRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quanterix Co. (NASDAQ:QTRX – Free Report).
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.